In summary, our study provides evidence that miR‐326/Sp1/KLF3 regulatory axis involves in lung cancer cell proliferation, migration and invasion, which provide leads for the further therapy to patients with lung cancer. The gene discussed is SP1; the disease is lung carcinoma.